Literature DB >> 23255530

Biofabrication of a PLGA-TCP-based porous bioactive bone substitute with sustained release of icaritin.

Xin-Hui Xie1,2, Xin-Luan Wang1,3, Ge Zhang1, Yi-Xin He1, Yang Leng4, Ting-Ting Tang5, Xiaohua Pan6, Ling Qin1,3.   

Abstract

A phytomolecule, icaritin, has been identified and shown to be osteopromotive for the prevention of osteoporosis and osteonecrosis. This study aimed to produce a bioactive poly (l-lactide-co-glycolide)-tricalcium phosphate (PLGA-TCP)-based porous scaffold incorporating the osteopromotive phytomolecule icaritin, using a fine spinning technology. Both the structure and the composition of icaritin-releasing PLGA-TCP-based scaffolds were evaluated by scanning electron microscopy (SEM). The porosity was quantified by both water absorption and micro-computed tomography (micro-CT). The mechanical properties were evaluated using a compression test. In vitro release of icaritin from the PLGA-TCP scaffold was quantified by high-performance liquid chromatography (HPLC). The attachment, proliferation and osteogenic differentiation of bone marrow mesenchymal stem cells (BMSCs) on the composite scaffold were evaluated. Both an in vitro cytotoxicity test and an in vivo test via muscular implantation were conducted to confirm the scaffold's biocompatibility. The results showed that the PLGA-TCP-icaritin composite scaffold was porous, with interconnected macro- (about 480 µm) and micropores (2-15 µm). The mechanical properties of the PLGA-TCP-icaritin scaffold were comparable with those of the pure PLGA-TCP scaffold, yet was spinning direction-dependent. Icaritin content was detected in the medium and increased with time. The PLGA-TCP-icaritin scaffold facilitated the attachment, proliferation and osteogenic differentiation of BMSCs. In vitro cytotoxicity test and in vivo intramuscular implantation showed that the composite scaffold had no toxicity with good biocompatibility. In conclusion, an osteopromotive phytomolecule, icaritin, was successfully incorporated into PLGA-TCP to form an innovative porous composite scaffold with sustained release of osteopromotive icaritin, and this scaffold had good biocompatibility and osteopromotion, suggesting its potential for orthopaedic applications.
Copyright © 2012 John Wiley & Sons, Ltd.

Entities:  

Keywords:  biocompatibility; cytotoxicity; icaritin; osteogenesis; poly(l-lactide-co-glycolide)/tricalcium phosphate; scaffold

Mesh:

Substances:

Year:  2012        PMID: 23255530     DOI: 10.1002/term.1679

Source DB:  PubMed          Journal:  J Tissue Eng Regen Med        ISSN: 1932-6254            Impact factor:   3.963


  13 in total

1.  Osseointegrative properties of electrospun hydroxyapatite-containing nanofibrous chitosan scaffolds.

Authors:  Michael E Frohbergh; Anya Katsman; Mark J Mondrinos; Collin T Stabler; Kurt D Hankenson; Jeffrey T Oristaglio; Peter I Lelkes
Journal:  Tissue Eng Part A       Date:  2014-12-16       Impact factor: 3.845

Review 2.  Traditional Chinese medicine promotes bone regeneration in bone tissue engineering.

Authors:  Zheng-Rong Gao; Yun-Zhi Feng; Ya-Qiong Zhao; Jie Zhao; Ying-Hui Zhou; Qin Ye; Yun Chen; Li Tan; Shao-Hui Zhang; Yao Feng; Jing Hu; Ze-Yue Ou-Yang; Marie Aimee Dusenge; Yue Guo
Journal:  Chin Med       Date:  2022-07-20       Impact factor: 4.546

Review 3.  Polyphenol-Enriched Composite Bone Regeneration Materials: A Systematic Review of In Vitro Studies.

Authors:  Kamila Checinska; Maciej Checinski; Katarzyna Cholewa-Kowalska; Maciej Sikora; Dariusz Chlubek
Journal:  Int J Mol Sci       Date:  2022-07-05       Impact factor: 6.208

4.  Bioactive PLGA/tricalcium phosphate scaffolds incorporating phytomolecule icaritin developed for calvarial defect repair in rat model.

Authors:  Guang-Sen Shi; Ying-Ying Li; Ya-Ping Luo; Jian-Feng Jin; Yu-Xin Sun; Li-Zhen Zheng; Yu-Xiao Lai; Long Li; Guo-Hui Fu; Ling Qin; Shi-Hui Chen
Journal:  J Orthop Translat       Date:  2020-06-07       Impact factor: 5.191

5.  Engineered three-dimensional scaffolds for enhanced bone regeneration in osteonecrosis.

Authors:  Tongtong Zhu; Yutao Cui; Mingran Zhang; Duoyi Zhao; Guangyao Liu; Jianxun Ding
Journal:  Bioact Mater       Date:  2020-04-17

Review 6.  Natural Products from Chinese Medicines with Potential Benefits to Bone Health.

Authors:  Chun-Tao Che; Man Sau Wong; Christopher Wai Kei Lam
Journal:  Molecules       Date:  2016-02-27       Impact factor: 4.411

7.  Use of a three-dimensional printed polylactide-coglycolide/tricalcium phosphate composite scaffold incorporating magnesium powder to enhance bone defect repair in rabbits.

Authors:  Wen Yu; Rui Li; Jing Long; Peng Chen; Angyang Hou; Long Li; Xun Sun; Guoquan Zheng; Haoye Meng; Yu Wang; Aiyuan Wang; Xiang Sui; Quanyi Guo; Sheng Tao; Jiang Peng; Ling Qin; Shibi Lu; Yuxiao Lai
Journal:  J Orthop Translat       Date:  2018-08-16       Impact factor: 5.191

8.  Use of a novel Screen-Enrich-Combine(-biomaterials) Circulating System to fill a 3D-printed open Ti6Al4V frame with mesenchymal stem cells/β-tricalcium phosphate to repair complex anatomical bone defects in load-bearing areas.

Authors:  Wenxiang Chu; Zhiqing Liu; Yaokai Gan; Yongyun Chang; Xin Jiao; Wenbo Jiang; Kerong Dai
Journal:  Ann Transl Med       Date:  2021-03

9.  Three-dimensional Printing in Maxillofacial Surgery: Hype versus Reality.

Authors:  Alaa Aldaadaa; Nazanin Owji; Jonathan Knowles
Journal:  J Tissue Eng       Date:  2018-04-20       Impact factor: 7.813

10.  Cryogenic 3D Printing of ß-TCP/PLGA Composite Scaffolds Incorporated With BpV (Pic) for Treating Early Avascular Necrosis of Femoral Head.

Authors:  Feng Li; Zhifu Cao; Kai Li; Ke Huang; Chengliang Yang; Ye Li; Chuanchuan Zheng; Yulu Ye; Tingjie Zhou; Haoqiang Peng; Jia Liu; Chong Wang; Kegong Xie; Yujin Tang; Liqiang Wang
Journal:  Front Bioeng Biotechnol       Date:  2022-01-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.